123 related articles for article (PubMed ID: 8843019)
1. Some acute effects of intracerebroventricular neuropeptide Y on insulin secretion and glucose metabolism in the rat.
Marks JL; Waite K
J Neuroendocrinol; 1996 Jul; 8(7):507-13. PubMed ID: 8843019
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and orexigenic effects of intracerebroventricular neuropeptide Y are attenuated by food deprivation.
Parikh R; Marks JL
J Neuroendocrinol; 1997 Oct; 9(10):789-95. PubMed ID: 9355048
[TBL] [Abstract][Full Text] [Related]
3. Intracerebroventricular neuropeptide Y acutely influences glucose metabolism and insulin sensitivity in the rat.
Marks JL; Waite K
J Neuroendocrinol; 1997 Feb; 9(2):99-103. PubMed ID: 9041362
[TBL] [Abstract][Full Text] [Related]
4. Effects of Intracerebroventricular Administration of Neuropeptide Y on Metabolic Gene Expression and Energy Metabolism in Male Rats.
Su Y; Foppen E; Fliers E; Kalsbeek A
Endocrinology; 2016 Aug; 157(8):3070-85. PubMed ID: 27267712
[TBL] [Abstract][Full Text] [Related]
5. Intracerebroventricular infusion of neuropeptide Y modulates VIP secretion in the fasting conscious dog.
Anastasiou OE; Yavropoulou MP; Kesisoglou I; Kotsa K; Yovos JG
Neuropeptides; 2009 Feb; 43(1):41-6. PubMed ID: 19058848
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracerebroventricular orexin-B on food intake in sheep.
Sartin JL; Dyer C; Matteri R; Buxton D; Buonomo F; Shores M; Baker J; Osborne JA; Braden T; Steele B
J Anim Sci; 2001 Jun; 79(6):1573-7. PubMed ID: 11424696
[TBL] [Abstract][Full Text] [Related]
7. Intracerebroventricular neuropeptide Y increases gastric and pancreatic secretion in the dog.
Geoghegan JG; Lawson DC; Cheng CA; Opara E; Taylor IL; Pappas TN
Gastroenterology; 1993 Oct; 105(4):1069-77. PubMed ID: 8405851
[TBL] [Abstract][Full Text] [Related]
8. Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.
Sainsbury A; Rohner-Jeanrenaud F; Grouzmann E; Jeanrenaud B
Neuroendocrinology; 1996 Apr; 63(4):318-26. PubMed ID: 8739887
[TBL] [Abstract][Full Text] [Related]
9. Effects of neuropeptide Y on insulin and glucagon secretion in the pig.
Ahrén B; Mårtensson H; Falck B
Neuropeptides; 1991 Sep; 20(1):49-55. PubMed ID: 1791925
[TBL] [Abstract][Full Text] [Related]
10. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity.
Zarjevski N; Cusin I; Vettor R; Rohner-Jeanrenaud F; Jeanrenaud B
Endocrinology; 1993 Oct; 133(4):1753-8. PubMed ID: 8404618
[TBL] [Abstract][Full Text] [Related]
11. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats.
Pierroz DD; Catzeflis C; Aebi AC; Rivier JE; Aubert ML
Endocrinology; 1996 Jan; 137(1):3-12. PubMed ID: 8536627
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats.
Catzeflis C; Pierroz DD; Rohner-Jeanrenaud F; Rivier JE; Sizonenko PC; Aubert ML
Endocrinology; 1993 Jan; 132(1):224-34. PubMed ID: 8380374
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hypothalamic neuropeptide Y gene expression by insulin.
Schwartz MW; Sipols AJ; Marks JL; Sanacora G; White JD; Scheurink A; Kahn SE; Baskin DG; Woods SC; Figlewicz DP
Endocrinology; 1992 Jun; 130(6):3608-16. PubMed ID: 1597158
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular neuropeptide Y produces hyperinsulinemia in the presence and absence of food.
Marks JL; Waite K; Davies L
Physiol Behav; 1996 Sep; 60(3):685-92. PubMed ID: 8873237
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y: direct and indirect action on insulin secretion in the rat.
Moltz JH; McDonald JK
Peptides; 1985; 6(6):1155-9. PubMed ID: 3914635
[TBL] [Abstract][Full Text] [Related]
16. Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways.
Baran K; Preston E; Wilks D; Cooney GJ; Kraegen EW; Sainsbury A
Diabetes; 2002 Jan; 51(1):152-8. PubMed ID: 11756335
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis.
Hanson ES; Dallman MF
J Neuroendocrinol; 1995 Apr; 7(4):273-9. PubMed ID: 7647769
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion in rats: effects of neuropeptide Y and noradrenaline.
Pettersson M; Ahrén B
Diabetes Res; 1990 Jan; 13(1):35-42. PubMed ID: 2097094
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin.
van den Hoek AM; Voshol PJ; Karnekamp BN; Buijs RM; Romijn JA; Havekes LM; Pijl H
Diabetes; 2004 Oct; 53(10):2529-34. PubMed ID: 15448080
[TBL] [Abstract][Full Text] [Related]
20. Central administration of prolactin-releasing peptide shifts the utilities of metabolic fuels from carbohydrate to lipids in chicks.
Tachibana T; Moriyama S; Khan MS; Sakamoto T
Physiol Behav; 2013 Aug; 120():40-5. PubMed ID: 23816984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
